310 related articles for article (PubMed ID: 28283778)
21. The lncRNA GATA3-AS1/miR-495-3p/CENPU axis predicts poor prognosis of breast cancer via the PLK1 signaling pathway.
Lin S; Zhao M; Lv Y; Mao G; Ding S; Peng F
Aging (Albany NY); 2021 Apr; 13(10):13663-13679. PubMed ID: 33902008
[TBL] [Abstract][Full Text] [Related]
22. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
Feng B; Wang R; Chen LB
Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675
[TBL] [Abstract][Full Text] [Related]
23. Integrated analysis of miRNA and mRNA expression in childhood medulloblastoma compared with neural stem cells.
Genovesi LA; Carter KW; Gottardo NG; Giles KM; Dallas PB
PLoS One; 2011; 6(9):e23935. PubMed ID: 21931624
[TBL] [Abstract][Full Text] [Related]
24. [miR-449a is a potential epigenetic biomarker for WNT subtype of medulloblastoma].
Li YX; Shao LW; Jiang T; Liu Y; Chang Q
Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):684-689. PubMed ID: 29050069
[No Abstract] [Full Text] [Related]
25. miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47.
Yang SY; Choi SA; Lee JY; Park AK; Wang KC; Phi JH; Koh EJ; Park WY; Park SH; Hwang DW; Jung HW; Kim SK
Oncotarget; 2015 Dec; 6(41):43712-30. PubMed ID: 26506238
[TBL] [Abstract][Full Text] [Related]
26. The long noncoding RNA linc-NeD125 controls the expression of medulloblastoma driver genes by microRNA sponge activity.
Laneve P; Po A; Favia A; Legnini I; Alfano V; Rea J; Di Carlo V; Bevilacqua V; Miele E; Mastronuzzi A; Carai A; Locatelli F; Bozzoni I; Ferretti E; Caffarelli E
Oncotarget; 2017 May; 8(19):31003-31015. PubMed ID: 28415684
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of SUN2, a novel tumor suppressor, mediates miR-221/222-induced malignancy in central nervous system embryonal tumors.
Hsieh TH; Chien CL; Lee YH; Lin CI; Hsieh JY; Chao ME; Liu DJ; Chu SS; Chen W; Lin SC; Ho DM; Liu RS; Lin CH; Wong TT; Wang HW
Carcinogenesis; 2014 Oct; 35(10):2164-74. PubMed ID: 24832085
[TBL] [Abstract][Full Text] [Related]
28. [MicroRNA383 regulates expression of PRDX3 in human medulloblastomas].
Wang XM; Zhang SF; Cheng ZQ; Peng QZ; Hu JT; Gao LK; Xu J; Jin HT; Liu HY
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):547-52. PubMed ID: 23157748
[TBL] [Abstract][Full Text] [Related]
29. The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients.
Kahl I; Mense J; Finke C; Boller AL; Lorber C; Győrffy B; Greve B; Götte M; Espinoza-Sánchez NA
J Cell Biochem; 2022 Mar; 123(3):581-600. PubMed ID: 35014077
[TBL] [Abstract][Full Text] [Related]
30. Exosomal miR-130b-3p targets SIK1 to inhibit medulloblastoma tumorigenesis.
Huang S; Xue P; Han X; Zhang C; Yang L; Liu L; Wang X; Li H; Fu J; Zhou Y
Cell Death Dis; 2020 Jun; 11(6):408. PubMed ID: 32483145
[TBL] [Abstract][Full Text] [Related]
31. Polo-like kinases in AML.
Berg T; Bug G; Ottmann OG; Strebhardt K
Expert Opin Investig Drugs; 2012 Aug; 21(8):1069-74. PubMed ID: 22667760
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma.
Bai AH; Milde T; Remke M; Rolli CG; Hielscher T; Cho YJ; Kool M; Northcott PA; Jugold M; Bazhin AV; Eichmüller SB; Kulozik AE; Pscherer A; Benner A; Taylor MD; Pomeroy SL; Kemkemer R; Witt O; Korshunov A; Lichter P; Pfister SM
Acta Neuropathol; 2012 Apr; 123(4):529-38. PubMed ID: 22134538
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of PLKs expression and prognosis in breast cancer.
Jiawei W; Xiajun B; Tian S; Xuzheng G; Zhenwang Z
Cancer Genet; 2022 Nov; 268-269():83-92. PubMed ID: 36206661
[TBL] [Abstract][Full Text] [Related]
34. SmSak, the second Polo-like kinase of the helminth parasite Schistosoma mansoni: conserved and unexpected roles in meiosis.
Long T; Vanderstraete M; Cailliau K; Morel M; Lescuyer A; Gouignard N; Grevelding CG; Browaeys E; Dissous C
PLoS One; 2012; 7(6):e40045. PubMed ID: 22768216
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma.
Venkataraman S; Birks DK; Balakrishnan I; Alimova I; Harris PS; Patel PR; Handler MH; Dubuc A; Taylor MD; Foreman NK; Vibhakar R
J Biol Chem; 2013 Jan; 288(3):1918-28. PubMed ID: 23212916
[TBL] [Abstract][Full Text] [Related]
36. miR miR on the wall, who's the most malignant medulloblastoma miR of them all?
Wang X; Holgado BL; Ramaswamy V; Mack S; Zayne K; Remke M; Wu X; Garzia L; Daniels C; Kenney AM; Taylor MD
Neuro Oncol; 2018 Feb; 20(3):313-323. PubMed ID: 28575493
[TBL] [Abstract][Full Text] [Related]
37. MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7-H3).
Kanchan RK; Perumal N; Atri P; Chirravuri Venkata R; Thapa I; Klinkebiel DL; Donson AM; Perry D; Punsoni M; Talmon GA; Coulter DW; Boue' DR; Snuderl M; Nasser MW; Batra SK; Vibhakar R; Mahapatra S
Brain Pathol; 2020 Jul; 30(4):732-745. PubMed ID: 32145124
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization.
Bhatia S; Baig NA; Timofeeva O; Pasquale EB; Hirsch K; MacDonald TJ; Dritschilo A; Lee YC; Henkemeyer M; Rood B; Jung M; Wang XJ; Kool M; Rodriguez O; Albanese C; Karam SD
Oncotarget; 2015 Apr; 6(11):8929-46. PubMed ID: 25879388
[TBL] [Abstract][Full Text] [Related]
39. Targeting sonic hedgehog-associated medulloblastoma through inhibition of Aurora and Polo-like kinases.
Markant SL; Esparza LA; Sun J; Barton KL; McCoig LM; Grant GA; Crawford JR; Levy ML; Northcott PA; Shih D; Remke M; Taylor MD; Wechsler-Reya RJ
Cancer Res; 2013 Oct; 73(20):6310-22. PubMed ID: 24067506
[TBL] [Abstract][Full Text] [Related]
40. MiR-34a deficiency accelerates medulloblastoma formation in vivo.
Thor T; Künkele A; Pajtler KW; Wefers AK; Stephan H; Mestdagh P; Heukamp L; Hartmann W; Vandesompele J; Sadowski N; Becker L; Garrett L; Hölter SM; Horsch M; Calzada-Wack J; Klein-Rodewald T; Racz I; Zimmer A; Beckers J; Neff F; Klopstock T; De Antonellis P; Zollo M; Wurst W; Fuchs H; Gailus-Durner V; Schüller U; de Angelis MH; Eggert A; Schramm A; Schulte JH
Int J Cancer; 2015 May; 136(10):2293-303. PubMed ID: 25348795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
